Table 2.
Male | Female | |||||||
---|---|---|---|---|---|---|---|---|
All | Caregivers | Non-caregivers | All | Caregivers | Non-caregivers | |||
(n=88) | (n=44) | (n=44) | (n=210) | (n=105) | (n=105) | |||
n (%) | n (%) | n (%) | p value | n (%) | n (%) | n (%) | p value | |
[n*] | [n*] | [n*] | [n*] | [n*] | [n*] | |||
High blood pressure (a) | 50 (56.8) | 32 (72.7) | 18 (40.9) | 0.005 | 89 (42.4) | 60 (57.1) | 29 (27.6) | < 0.001 |
[receiving medication *] | [28] | [13] | [15] | [46] | [22] | [24] | ||
eGFR < 60 (b) | 13 (14.8) | 7 (15.9) | 6 (13.6) | 1.000 | 60 (28.6) | 50 (47.6) | 10 (9.5) | < 0.001 |
Dyslipidemia (c) | 41 (46.6) | 15 (34.1) | 26 (59.1) | 0.032 | 123 (58.6) | 50 (47.6) | 73 (69.5) | 0.002 |
[receiving medication *] | [12] | [2] | [10] | [41] | [11] | [30] | ||
Liver function disorder (d) | 31 (35.2) | 8 (18.2) | 23 (52.3) | 0.002 | 47 (22.4) | 20 (19.0) | 27 (25.7) | 0.321 |
[receiving medication *] | [9] | [0] | [9] | [8] | [1] | [7] | ||
Hyperuricemia (e) | 21 (23.9) | 8 (18.2) | 13 (29.5) | 0.317 | 6 (2.9) | 2 (1.9) | 4 (3.8) | 0.683 |
[receiving medication *] | [7] | [4] | [3] | [0] | [0] | [0] | ||
Hyperglycemia (f) | 17 (19.3) | 6 (13.6) | 11 (25.0) | 0.280 | 11 (5.2) | 3 (2.9) | 8 (7.6) | 0.214 |
[receiving medication *] | [15] | [4] | [11] | [11] | [3] | [8] |
(a) Systolic blood pressure (SBP) 140 and more or diastolic blood pressure (DBP) 90 and more or receiving medication.
(b) Less than 60 mL/min/1.73 m2.
(c) Less than 40 mg/dL HDL-C or 120 mg/dL LDL-C and more or receiving medication.
(d) More than 30 IU/L AST or more than 30 IU/L ALT or more than 50 IU/L γ-GTP or receiving medication with the exception of viral hepatitis.
(e) UA 7.0 mg/dL and more or receiving medication.
(f) HbA1c 6.5% and more or receiving medication.
* The number of persons receiving medication was included in the total number of persons above.